Literature DB >> 25099198

Examining unidimensionality and improving reliability for the eight subscales of the SF-36 in opioid-dependent patients using Rasch analysis.

Yu-Yu Hsiao1, Ching-Lin Shih, Wan-Hui Yu, Cheng-Hsi Hsieh, Ching-Lin Hsieh.   

Abstract

PURPOSE: The Medical Outcome Study Short Form 36 (SF-36) is one of the most commonly used questionnaires for monitoring the Health-Related Quality of Life (HRQOL) of opioid-dependent patients. However, the unidimensionality and reliability of the SF-36 have not been verified in opioid-dependent patients. The aim of this study was to examine the unidimensionality and to improve the test reliability of the SF-36 for use in opioid-dependent patients.
METHODS: A total of 583 opioid-dependent patients were recruited in the study. Unidimensionality was examined by conducting unidimensional Rasch analysis. Item fit statistics and principle component analysis were used to check the item-model fit in each of the eight subscales of the SF-36. Reliability was evaluated by applying both unidimensional and multidimensional Rasch analyses.
RESULTS: After three misfitting items were excluded, the remaining items of each subscale in the SF-36 represented a single construct. The test reliabilities (0.80-0.87) yielded by the multidimensional approach were much higher than those (0.68-0.82) produced by the unidimensional approach.
CONCLUSION: The remaining 32 items of the SF-36 are appropriate for evaluating the HRQOL in opioid-dependent patients in terms of unidimensionality. Additionally, the test scores produced by the multidimensional approach were more accurate than those obtained by the unidimensional approach.

Entities:  

Mesh:

Year:  2014        PMID: 25099198     DOI: 10.1007/s11136-014-0771-z

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  28 in total

1.  Improving measurement precision of test batteries using multidimensional item response models.

Authors:  Wen-Chung Wang; Po-Hsi Chen; Ying-Yao Cheng
Journal:  Psychol Methods       Date:  2004-03

2.  Validating, improving reliability, and estimating correlation of the four subscales in the WHOQOL-BREF using multidimensional Rasch analysis.

Authors:  Wen-Chung Wang; Grace Yao; Yih-Jian Tsai; Jung-Der Wang; Ching-Lin Hsieh
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

3.  Outcome measurement in functional somatic syndromes: SF-36 summary scores and some scales were not valid.

Authors:  Andreas Schröder; Eva Oernboel; Rasmus W Licht; Michael Sharpe; Per Fink
Journal:  J Clin Epidemiol       Date:  2011-07-20       Impact factor: 6.437

4.  Tests of data quality, scaling assumptions, reliability, and construct validity of the SF-36 health survey in people who abuse heroin.

Authors:  En-Chi Chiu; I-Ping Hsueh; Cheng-Hsi Hsieh; Ching-Lin Hsieh
Journal:  J Formos Med Assoc       Date:  2012-07-25       Impact factor: 3.282

Review 5.  Characteristics and consequences of heroin use among older adults in the United States: a review of the literature, treatment implications, and recommendations for further research.

Authors:  Daniel Rosen; Amanda Hunsaker; Steven M Albert; Jack R Cornelius; Charles F Reynolds
Journal:  Addict Behav       Date:  2010-12-10       Impact factor: 3.913

6.  Suicide and other-cause mortality among heroin users in Taiwan: a prospective study.

Authors:  Charles T C Lee; Vincent C H Chen; Happy K L Tan; Sun-Yuan Chou; Kuen-Hong Wu; Chia-Hsiang Chan; Michael Gossop
Journal:  Addict Behav       Date:  2013-03-21       Impact factor: 3.913

7.  Cross-diagnostic validity of the SF-36 physical functioning scale in patients with stroke, multiple sclerosis and amyotrophic lateral sclerosis: a study using Rasch analysis.

Authors:  Annet J Dallmeijer; Vincent de Groot; Leo D Roorda; Vera P M Schepers; Eline Lindeman; Leonard H van den Berg; Anita Beelen; Joost Dekker
Journal:  J Rehabil Med       Date:  2007-03       Impact factor: 2.912

8.  Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire.

Authors:  C F Ryan; J M White
Journal:  Addiction       Date:  1996-01       Impact factor: 6.526

9.  Use of the SF-36 in the evaluation of a drug detoxification program.

Authors:  Dirk Richter; Bernd Eikelmann; Klaus Berger
Journal:  Qual Life Res       Date:  2004-06       Impact factor: 4.147

10.  How useful are the SF-36 sub-scales in older people? Mokken scaling of data from the HALCyon programme.

Authors:  Gita D Mishra; Catharine R Gale; Avan Aihie Sayer; Cyrus Cooper; Elaine M Dennison; Lawrence J Whalley; Leone Craig; Diana Kuh; Ian J Deary
Journal:  Qual Life Res       Date:  2011-01-12       Impact factor: 4.147

View more
  4 in total

1.  PROMIS PF CAT Outperforms the ODI and SF-36 Physical Function Domain in Spine Patients.

Authors:  Darrel S Brodke; Vadim Goz; Maren W Voss; Brandon D Lawrence; William Ryan Spiker; Man Hung
Journal:  Spine (Phila Pa 1976)       Date:  2017-06-15       Impact factor: 3.241

2.  Psychometric properties of the painDETECT questionnaire in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: Rasch analysis and test-retest reliability.

Authors:  Signe Rifbjerg-Madsen; Eva Ejlersen Wæhrens; Bente Danneskiold-Samsøe; Kirstine Amris
Journal:  Health Qual Life Outcomes       Date:  2017-05-22       Impact factor: 3.186

3.  Evaluating the Longitudinal Item and Category Stability of the SF-36 Full and Summary Scales Using Rasch Analysis.

Authors:  Reinie Cordier; Ted Brown; Lindy Clemson; Julie Byles
Journal:  Biomed Res Int       Date:  2018-11-04       Impact factor: 3.411

4.  Psychometric properties of the Korean version of the medical outcomes study HIV health survey: results from a multicenter survey in Korea.

Authors:  Eun-Jung Shim; Hyeju Ha; Sun Hee Lee; Nam Joong Kim; Eu Suk Kim; Ji Hwan Bang; Kyoung-Ho Song; Bo Kyung Sohn; Hye Youn Park; Kyung-Lak Son; Heesung Hwang; Kwang-Min Lee; Bong-Jin Hahm
Journal:  Health Qual Life Outcomes       Date:  2018-05-15       Impact factor: 3.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.